Speaker illustration

Professor Peter M Nilsson

Lund University, Malmo (Sweden)

Born 1953. Professor of Clinical Cardiovascular Reseach at the Lund University, Sweden, since 2008. Served in the ESH Board and more recently as the chair of the ISH-RAG Europe group. Main interest is hypertension, type 2 diabetes and early life programming of adult cardiometabolic health.

Meet the trialist - CAMELLIA-TIMI 61 - Cardiovascular and Metabolic Effects of Lorcaserin in Overweight and Obese Patients-Thrombolysis in Myocardial Infarction 61

Event: ESC Congress 2018

Topic: Pharmacotherapy

Session type: Late-Breaking Science

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb